Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |